Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugs

Lang K, Drell TL t., Lindecke A, Niggemann B, Zaenker KS, Entschladen F, Kaltschmidt C (2004)
Int J Cancer 112 112(2): 231-238.

Journal Article | Published | English

No fulltext has been uploaded

Author
; ; ; ; ; ;
Publishing Year
ISSN
eISSN
PUB-ID

Cite this

Lang K, Drell TL t., Lindecke A, et al. Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugs. Int J Cancer 112. 2004;112(2):231-238.
Lang, K., Drell, T. L. t., Lindecke, A., Niggemann, B., Zaenker, K. S., Entschladen, F., & Kaltschmidt, C. (2004). Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugs. Int J Cancer 112, 112(2), 231-238.
Lang, K., Drell, T. L. t., Lindecke, A., Niggemann, B., Zaenker, K. S., Entschladen, F., and Kaltschmidt, C. (2004). Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugs. Int J Cancer 112 112, 231-238.
Lang, K., et al., 2004. Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugs. Int J Cancer 112, 112(2), p 231-238.
K. Lang, et al., “Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugs”, Int J Cancer 112, vol. 112, 2004, pp. 231-238.
Lang, K., Drell, T.L. t., Lindecke, A., Niggemann, B., Zaenker, K.S., Entschladen, F., Kaltschmidt, C.: Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugs. Int J Cancer 112. 112, 231-238 (2004).
Lang, K., Drell, T. L. t., Lindecke, A., Niggemann, B., Zaenker, K. S., Entschladen, F., and Kaltschmidt, Christian. “Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugs”. Int J Cancer 112 112.2 (2004): 231-238.
This data publication is cited in the following publications:
This publication cites the following data publications:

83 Citations in Europe PMC

Data provided by Europe PubMed Central.

Re-Use of Established Drugs for Anti-Metastatic Indications.
Entschladen F, Thyssen DA, Drell DW., Cells 5(1), 2016
PMID: 26771645
β-Adrenergic receptors suppress Rap1B prenylation and promote the metastatic phenotype in breast cancer cells.
Wilson JM, Lorimer E, Tyburski MD, Williams CL., Cancer Biol. Ther. 16(9), 2015
PMID: 26209110
The substance P/NK-1 receptor system: NK-1 receptor antagonists as anti-cancer drugs.
Munoz M, Covenas R, Esteban F, Redondo M., J. Biosci. 40(2), 2015
PMID: 25963269
Mechanisms of propranolol action in infantile hemangioma.
Kum JJ, Khan ZA., Dermatoendocrinol 6(1), 2014
PMID: 26413184
Activity of β2-adrenergic receptor in oral squamous cell carcinoma is mediated by overexpression of the ADRBK2 gene: a pilot study.
Perez-Sayans M, Somoza-Martin JM, Barros-Angueira F, Gayoso-Diz P, Otero-Rey EM, Gandra-Rey JM, Garcia-Garcia A., Biotech Histochem 87(3), 2012
PMID: 21916780

48 References

Data provided by Europe PubMed Central.

Calcium regulation of neuronal gene expression.
West AE, Chen WG, Dalva MB, Dolmetsch RE, Kornhauser JM, Shaywitz AJ, Takasu MA, Tao X, Greenberg ME., Proc. Natl. Acad. Sci. U.S.A. 98(20), 2001
PMID: 11572963
Norepinephrine increases I kappa B alpha expression in astrocytes.
Gavrilyuk V, Dello Russo C, Heneka MT, Pelligrino D, Weinberg G, Feinstein DL., J. Biol. Chem. 277(33), 2002
PMID: 12050158
Protein kinase C-alpha is an upstream activator of the IkappaB kinase complex in the TPA signal transduction pathway to NF-kappaB in U2OS cells.
Vertegaal AC, Kuiperij HB, Yamaoka S, Courtois G, van der Eb AJ, Zantema A., Cell. Signal. 12(11-12), 2000
PMID: 11152962
Transcription factor CREB and its stimulus-dependent phosphorylation in cell and explant cultures of the bovine subcommissural organ.
Schoniger S, Maronde E, Kopp MD, Korf HW, Nurnberger F., Cell Tissue Res. 308(1), 2002
PMID: 12012213
Dopamine induces a PI3-kinase-independent activation of Akt in striatal neurons: a new route to cAMP response element-binding protein phosphorylation.
Brami-Cherrier K, Valjent E, Garcia M, Pages C, Hipskind RA, Caboche J., J. Neurosci. 22(20), 2002
PMID: 12388598
Nuclear factor-kappa B is involved in the catecholaminergic suppression of immunocompetent cells.
Bergquist J, Ohlsson B, Tarkowski A., Ann. N. Y. Acad. Sci. 917(), 2000
PMID: 11268354
Substance P up-regulates macrophage inflammatory protein-1beta expression in human T lymphocytes.
Guo CJ, Lai JP, Luo HM, Douglas SD, Ho WZ., J. Neuroimmunol. 131(1-2), 2002
PMID: 12458047
AP-1: one switch for many signals.
Wisdom R., Exp. Cell Res. 253(1), 1999
PMID: 10579922
Gene transcription through activation of G-protein-coupled chemoattractant receptors.
Ye RD, Pan Z, Kravchenko VV, Browning DD, Prossnitz ER., Gene Expr. 5(4-5), 1996
PMID: 8723387
Seven-transmembrane receptors.
Pierce KL, Premont RT, Lefkowitz RJ., Nat. Rev. Mol. Cell Biol. 3(9), 2002
PMID: 12209124
Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes.
Luttrell LM, Ferguson SS, Daaka Y, Miller WE, Maudsley S, Della Rocca GJ, Lin F, Kawakatsu H, Owada K, Luttrell DK, Caron MG, Lefkowitz RJ., Science 283(5402), 1999
PMID: 9924018

Hodgson, Am J Physiol Cell Physiol 281(), 2001
Gelsolin functions as a metastasis suppressor in B16-BL6 mouse melanoma cells and requirement of the carboxyl-terminus for its effect.
Fujita H, Okada F, Hamada J, Hosokawa M, Moriuchi T, Koya RC, Kuzumaki N., Int. J. Cancer 93(6), 2001
PMID: 11519036
Tissue microarray analysis of cytoskeletal actin-associated biomarkers gelsolin and E-cadherin in urothelial carcinoma.
Rao J, Seligson D, Visapaa H, Horvath S, Eeva M, Michel K, Pantuck A, Belldegrun A, Palotie A., Cancer 95(6), 2002
PMID: 12216092
Correlation of Ki-67 and gelsolin expression to clinical outcome in renal clear cell carcinoma.
Visapaa H, Bui M, Huang Y, Seligson D, Tsai H, Pantuck A, Figlin R, Rao JY, Belldegrun A, Horvath S, Palotie A., Urology 61(4), 2003
PMID: 12670587
MARCKS: a case of molecular exaptation?
Ramsden JJ., Int. J. Biochem. Cell Biol. 32(5), 2000
PMID: 10736562
MARCKS functions as a novel growth suppressor in cells of melanocyte origin.
Brooks G, Brooks SF, Goss MW., Carcinogenesis 17(4), 1996
PMID: 8625478
A genetic model for colorectal tumorigenesis.
Fearon ER, Vogelstein B., Cell 61(5), 1990
PMID: 2188735

Export

0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®

Sources

PMID: 15352035
PubMed | Europe PMC

Search this title in

Google Scholar